Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB06366_nanopub.RA5A1317DLhlq1qNKjEkkM_ysqwLMui2jV85a_pn-sq2g#assertion>. }
Showing items 1 to 18 of
18
with 100 items per page.
- drugbank:DB06366 type drugbank_vocabulary:Drug assertion.
- drugbank:DB06366 label "Pertuzumab [drugbank:DB06366]" assertion.
- drugbank:DB06366 seeAlso DB06366 assertion.
- drugbank:DB06366 seeAlso perjeta.html assertion.
- drugbank:DB06366 identifier "drugbank:DB06366" assertion.
- drugbank:DB06366 description "Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. FDA approved June 8, 2012." assertion.
- drugbank:DB06366 title "Pertuzumab" assertion.
- drugbank:DB06366 bio2rdf_vocabulary:identifier "DB06366" assertion.
- drugbank:DB06366 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB06366 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB06366" assertion.
- drugbank:DB06366 bio2rdf_vocabulary:x-identifiers.org DB06366 assertion.
- drugbank:DB06366 drugbank_vocabulary:drugbank-id "DB06366" assertion.
- drugbank:DB06366 drugbank_vocabulary:x-cas cas:380610-27-5 assertion.
- drugbank:DB06366 drugbank_vocabulary:x-ahfs ahfs:10:00 assertion.
- drugbank:DB06366 drugbank_vocabulary:x-atc atc:L01XC13 assertion.
- drugbank:DB06366 drugbank_vocabulary:x-kegg kegg:D05446 assertion.
- drugbank:DB06366 drugbank_vocabulary:x-wikipedia wikipedia:Pertuzumab assertion.
- drugbank:DB06366 drugbank_vocabulary:x-ndc ndc:50242-145-01 assertion.